Maze Therapeutics, Inc. [MAZE] - Maze Therapeutics appoints Paula A. Johnson and Sophie Kornowski as directors
On August 13, 2026, Maze Therapeutics, Inc. appointed Paula A. Johnson, M.D., M.P.H. as a Class III director and Sophie Kornowski, Pharm.D. as a Class I director, with terms expiring at the 2028 and 2029 annual meetings of stockholders, respectively.
Why this matters
Generating analysis…